RT Journal
A1 Hampton T
T1 GEne therapy for hearing loss
JF JAMA
JO JAMA
YR 2012
FD September 5
VO 308
IS 9
SP 853
OP 853
DO 10.1001/2012.jama.10869
UL http://dx.doi.org/10.1001/2012.jama.10869
AB 
Investigators at the University of California, San Francisco, and colleagues used mice with hereditary deafness caused by a mutation in the gene that encodes the vesicular glutamate transporter 3 (VGLUT3) protein, which is crucial for inner hair cells to send signals that enable hearing. Previous research indicates that a mutation in the human version of this gene may play a role in some cases of congenital hearing loss in people.